Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Share-based Compensation (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Share-based Compensation readings, the most recent being $337000.0 for Q4 2023.

  • On a quarterly basis, Share-based Compensation rose 69.35% to $337000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $1.2 million, a 103.63% increase, with the full-year FY2025 number at $2.7 million, up 85.74% from a year prior.
  • Share-based Compensation hit $337000.0 in Q4 2023 for Elicio Therapeutics, down from $339000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $5.1 million in Q1 2021 to a low of $31000.0 in Q1 2022.
  • Median Share-based Compensation over the past 4 years was $585500.0 (2020), compared with a mean of $1.2 million.
  • Biggest five-year swings in Share-based Compensation: tumbled 99.39% in 2022 and later surged 622.58% in 2023.
  • Elicio Therapeutics' Share-based Compensation stood at $1.2 million in 2020, then soared by 74.01% to $2.0 million in 2021, then crashed by 90.16% to $199000.0 in 2022, then soared by 69.35% to $337000.0 in 2023.
  • The last three reported values for Share-based Compensation were $337000.0 (Q4 2023), $339000.0 (Q3 2023), and $279000.0 (Q2 2023) per Business Quant data.